Please use this identifier to cite or link to this item: http://univ-bejaia.dz/dspace/123456789/25054
Title: The action of B2agonists formoterol and salbutamol on non -alcoholic fatty liver disease induced by a high -fat diet (HFD)biochemical approaches .
Authors: Debbou, Melissa
Debbou, Yassina
Amirouche, Adel (enc)
Keywords: Formoterol
B2-agonistes
Salbutamol
Issue Date: 2024
Publisher: Université de béjaia
Abstract: Non-alcoholic fatty liver disease (NAFLD) is a common condition associated with obesity and metabolic syndrome, affecting approximately 25% of the global population. Our study explores the development of an effective treatment for non-alcoholic fatty liver disease (NAFLD), a condition for which there is currently no specific treatment. We studied the use of β2-agonists, such as formoterol, as a potential treatment for NAFLD, targeting lipid metabolism and inflammation. Rats fed a high-fat diet were divided into four groups: negative control, high-fat diet, treatment with formoterol, and treatment with salbutamol. Treatments were administered daily by injection for two weeks. Tissue and serum samples were analyzed to assess treatment effects. Treatment with formoterol and salbutamol significantly reduced adipose tissue weight and levels of liver enzymes (AST, ALT, GAMMA-GT), suggesting hepatic protection. β2- agonists show promising therapeutic potential for NAFLD, reducing hepatic fat accumulation and improving liver function. These findings offer prospects for future treatments targeting lipid metabolism and inflammation. Further research is needed to confirm these benefits
Description: Option :Applied biochemistry
URI: http://univ-bejaia.dz/dspace/123456789/25054
Appears in Collections:Mémoire de Master

Files in This Item:
File Description SizeFormat 
The action of B2agonists formoterol and salbutamol on non -alcoholic.pdf1.74 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.